EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States
EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States
On Tuesday, Milestone Scientific Inc (NYSE:MLSS) announced that Novitas Solutions, Inc., a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the company's CompuFlo Epidural System under the American Medical Association's (AMA) technology-specific Category III CPT code CPT0777T (real-time pressure-sensing epidural guidance system when used in conjunction with a primary ESI procedure).
周二，Milestone Scientific Inc. (NYSE:MLSS)宣布，医疗保险权利判定机构（JMAC）Novitas Solutions，Inc.已经根据美国医学协会(AMA)的技术特定代码 第III CPT代码CPT777万亿（即实时压力感应硬膜外导航系统与初级ESI程序相结合使用时的硬膜外导航系统）为该公司的CompuFlo Epidural系统授予了医疗保险(b)医生支付比率。
This new price assignment applies to two Medicare regions:
这个新的价格分配适用于两个医疗保险区域：
- Jurisdiction L (JL) includes Delaware, District of Columbia, Maryland, New Jersey, and Pennsylvania.
- Jurisdiction H (JH) includes Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.
- L大单（JL）包括特拉华州，哥伦比亚特区，马里兰州，新泽西州和宾夕法尼亚州。
- H大单（JH）包括阿肯色州，科罗拉多州，路易斯安那州，密西西比州，新墨西哥州，俄克拉荷马州和德克萨斯州。
The pricing assignment by Novitas represents a significant step forward in Milestone Scientific's strategy to ensure broad coverage and appropriate payment for the CompuFlo technology when deemed medically necessary and clinically appropriate for Medicare beneficiaries.
Novitas的价格分配代表了Milestone Scientific确保CompuFlo技术在对医保受益人进行医疗必要性和临床适当性评估时获得广泛覆盖和适当支付的重要一步。
This decision follows the recently announced Medicare Jurisdiction N (JN) pricing assignment in Florida by First Coast Service Options Inc.
此决定是继First Coast Service Options Inc.最近宣布向佛罗里达医疗保险区域N（JN）的医疗保险价格分配之后做出的。
Also Read: EXCLUSIVE: Milestone Scientific Announces Favorable Medicare Pricing For CompuFlo Epidural System For Back Pain Covering Florida.
阅读更多: Milestone Scientific宣布CompuFlo脊柱后路硬膜外导航系统获得佳美医疗价格优惠。
An estimated 3.0 million epidural steroid injection (ESI) procedures are performed yearly in these three jurisdictions (JL, JH, JN), representing approximately one-third of the total ESI procedures for treating chronic back pain in the United States.
每年在这三个医疗保险区域（JL，JH，JN）中进行约300万次硬膜外肾上腺皮质类固醇注射（ESI）程序，对治疗慢性背痛的总ESI程序数量的约三分之一。
Additionally, Medicare is expected to account for up to 40% of the clinical practice volume, representing an initial addressable market of approximately $250 million among Medicare patients in these three jurisdictions, the company said.
此外，该公司表示，医疗保险预计将占据最多40%的临床实践成交量，这代表了这三个医疗保险区域内约25000万美元的初始可寻址市场。
The CompuFlo Epidural System uses Milestone Scientific's patented Dynamic Pressure Sensing technology, which provides real-time feedback to ensure accurate needle placement during epidural procedures. This technology is designed to reduce the morbidity, pain, and discomfort associated with traditional epidural techniques.
CompuFlo Epidural System采用Milestone Scientific的专利动态压力传感技术，可以提供实时反馈，以确保硬膜外程序导管的准确放置。这种技术旨在减少传统硬膜外技术所带来的发病率、疼痛和不适。
Price Action: MLSS stock is trading lower by 4.49% at $0.83 premarket at the last check on Tuesday.
股价行动：截至周二最后交易时段，MLSS股价预市下跌4.49%，报0.83美元。
- AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst.
- AnaptysBio调查用药可能比Eli Lilly的更具有效性:分析师。